Evidence map›Paper›PMID 32218234›Full record

ReviewBrain sciences2020

The

Donnamay T Brown, James C Vickers, Kimberley E Stuart, Katerina Cechova, David D Ward

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Disruption of BDNF signalling in neuropathologies.Biochemical Society transactions · 2026
    Review
  7. BDNF-amyloid-Frontiers in molecular neuroscience · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Interaction between miR-142-3p andInternational journal of molecular sciences · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Potential role ofFrontiers in aging neuroscience · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Donnamay T BrownWicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart 7001, Tasmania, Australia.
James C VickersWicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart 7001, Tasmania, Australia.
Kimberley E StuartWicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart 7001, Tasmania, Australia.
Katerina CechovaMemory Clinic, Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 15006 Prague, Czech Republic.
David D WardWicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart 7001, Tasmania, Australia.
University of Tasmania · AUCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain-derived neurotropic factor (BDNF) is an abundant and multi-function neurotrophin in the brain. It is released following neuronal activity and is believed to be particularly important in strengthening neural networks. A common variation in the

Indexed as

ageingAlzheimer’s diseaseBDNFBDNF Val66Metbrain-derived neurotrophic factorcognitive functiondementia

Identifiers

PMID32218234
PMCPMC7226504
OpenAlexW3013420477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.